Karyopharm Therapeutics
KPTI
KPTI
80 hedge funds and large institutions have $345M invested in Karyopharm Therapeutics in 2017 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 31 increasing their positions, 22 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
0% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 13
7% less funds holding
Funds holding: 86 → 80 (-6)
Holders
80
Holding in Top 10
–
Calls
$2.04M
Puts
$790K
Top Buyers
| 1 | +$32.1M | |
| 2 | +$4.87M | |
| 3 | +$4.37M | |
| 4 |
IHM
Iguana Healthcare Management
New York
|
+$3.53M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
+$3.46M |
Top Sellers
| 1 | -$5.81M | |
| 2 | -$5.2M | |
| 3 | -$2.8M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$1.06M |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$987K |